E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers Tenders > Headlines for 2009 > News item
Published on 6/5/2009 in the Prospect News Convertibles Daily.

Antigenics to exchange $1.5 million 5.25% convertibles for shares

By Susanna Moon

Chicago, June 5 - Antigenics Inc. said it agreed to issue 477,528 common shares in exchange for $1.5 million of its 5.25% convertible senior notes due February 2025 held by Wolverine Convertible Arbitrage Fund Trading Ltd.

Antigenics is a New York-based biotechnology company with a focus on cancers and infectious diseases.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.